A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
Condition: Ulcerative Colitis (UC) Interventions: Drug: Mesalamine; Drug: Placebo Sponsor: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials
HCQ for Non Europeans With Mild to Severe UC
Condition: Ulcerative Colitis (Disorder) Interventions: Drug: Hydroxychloroquine; Drug: Mesalamine Sponsors: Icahn School of Medicine at Mount Sinai; Crohn's and Colitis Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2021 Category: Research Source Type: clinical trials